Publications 2025

Gamboa D, Kabashi S, Jørgenrud B, Lerdal A, Nordby G, Bogstrand ST (2025)
Missed opportunities: the detection and management of at-risk drinking and illicit drug use in acutely hospitalized patients
Adv Drug Alcohol Res, 5, 14149
DOI 10.3389/adar.2025.14149, PubMed 40110028

Skjelland D, Jørgenrud BM, Gundersen K, Bjørnaas MA, Brekke M, Dalaker VM, Furuhaugen H, Vallersnes OM (2025)
Gamma-hydroxybutyrate poisoning: clinical diagnosis versus laboratory findings
Clin Toxicol (Phila), 63 (4), 253-260
DOI 10.1080/15563650.2025.2463700, PubMed 40272047

Publications 2024

Gamboa D, Kabashi S, Jørgenrud B, Lerdal A, Nordby G, Bogstrand ST (2024)
Is alcohol and psychoactive medication use associated with excess hospital length-of-stay and admission frequency? A cross-sectional, observational study
BMC Emerg Med, 24 (1), 63
DOI 10.1186/s12873-024-00979-y, PubMed 38627626

Jørgenrud B, McQuade T, Maria MH, Nilsson G, Berg T (2024)
Buffer-free high pH mobile phase LC-MS/MS for determination of the alcohol biomarker phosphatidylethanol 16:0/18:1 and 20 drugs and metabolites in whole blood
Talanta, 282, 126964
DOI 10.1016/j.talanta.2024.126964, PubMed 39366246

Jørgenrud BM, Bråthen CC, Steinson Stenehjem J, Kristiansen T, Rosseland LA, Bogstrand ST (2024)
Identifying excessive chronic alcohol use with phosphatidylethanol in patients with suspected severe injury-results from the IDART study
Alcohol Alcohol, 59 (3)
DOI 10.1093/alcalc/agae014, PubMed 38497164

Årving A, Hilberg T, Vigerust EW, Jørgenrud B, Bogstrand ST, Mørland J, Høiseth G (2024)
Assessing alcohol consumption across phosphatidylethanol levels using HDL-cholesterol as a predictor
Alcohol Alcohol, 60 (1)
DOI 10.1093/alcalc/agae085, PubMed 39671567

Publications 2023

Bråthen CC, Jørgenrud BM, Bogstrand ST, Gjerde H, Rosseland LA, Kristiansen T (2023)
Prevalence of use and impairment from drugs and alcohol among trauma patients: A national prospective observational study
Injury, 54 (12), 111160
DOI 10.1016/j.injury.2023.111160, PubMed 37944451

Publications 2022

Maria MH, Jørgenrud BM, Berg T (2022)
Determination of eight phosphatidylethanol homologues in blood by reversed phase liquid chromatography-tandem mass spectrometry - How to avoid co-elution of phosphatidylethanols and unwanted phospholipids
J Chromatogr A, 1684, 463566
DOI 10.1016/j.chroma.2022.463566, PubMed 36306689

Publications 2021

Jørgenrud B, Furuhaugen H, Gjerde H (2021)
Prevalence and Correlates of Illicit Drug Use among Norwegian Nightlife Patrons
Subst Use Misuse, 56 (11), 1697-1706
DOI 10.1080/10826084.2021.1949613, PubMed 34251973

Jørgenrud B, Kabashi S, Nadezhdin A, Bryun E, Koshkina E, Tetenova E, Lerdal A, Norby G, Kolgashkin A, Petukhov A, Perekhodov S, Davydova E, Vindenes V, Gamboa D, Bogstrand ST (2021)
The Association between the Alcohol Biomarker Phosphatidylethanol (PEth) and Self-Reported Alcohol Consumption among Russian and Norwegian Medical Patients
Alcohol Alcohol, 56 (6), 726-736
DOI 10.1093/alcalc/agab013, PubMed 33677484

Kabashi S, Gamboa D, Vindenes V, Berg T, Hilberg TA, Jørgenrud B, Lerdal A, Bogstrand ST (2021)
Multimorbidity, psychoactive substance use and psychological distress among acute medically ill patients: a cross-sectional study
BMJ Open, 11 (11), e052428
DOI 10.1136/bmjopen-2021-052428, PubMed 34815283

Publications 2020

Gamboa D, Jørgenrud B, Bryun EA, Vindenes V, Koshkina EA, Nadezhdin AV, Kabashi S, Tetenova EJ, Berg T, Nyman AAT, Kolgashkin AJ, Petukhov AE, Perekhodov SN, Davydova EN, Lerdal A, Nordby G, Bogstrand ST (2020)
Prevalence of psychoactive substance use among acutely hospitalised patients in Oslo and Moscow: a cross-sectional, observational study
BMJ Open, 10 (9), e032572
DOI 10.1136/bmjopen-2019-032572, PubMed 32948540

Jørgenrud B, Skadberg E, de Carvalho Ponce J, Furuhaugen H, Berg T (2020)
Determination of the alcohol biomarker phosphatidylethanol 16:0/18:1 and 33 compounds from eight different drug classes in whole blood by LC-MS/MS
J Pharmacol Toxicol Methods, 107, 106939
DOI 10.1016/j.vascn.2020.106939, PubMed 33257303

Publications 2018

Berg T, Eliassen E, Jørgenrud B, Kabashi S, Petukhov A, Bogstrand ST (2018)
Determination of phosphatidylethanol 16:0/18:1 in whole blood by 96-well supported liquid extraction and UHPLC-MS/MS
J Clin Lab Anal, 33 (1), e22631
DOI 10.1002/jcla.22631, PubMed 30047172

Jørgenrud B, Bogstrand ST, Furuhaugen H, Jamt REG, Vindenes V, Gjerde H (2018)
Association between speeding and use of alcohol and medicinal and illegal drugs and involvement in road traffic crashes among motor vehicle drivers
Traffic Inj Prev, 19 (8), 779-785
DOI 10.1080/15389588.2018.1518577, PubMed 30681887

Publications 2016

Jørgenrud B, Stene LC, Tapia G, Bøås H, Pepaj M, Berg JP, Thorsby PM, Orešič M, Hyötyläinen T, Rønningen KS (2016)
Longitudinal plasma metabolic profiles, infant feeding, and islet autoimmunity in the MIDIA study
Pediatr Diabetes, 18 (2), 111-119
DOI 10.1111/pedi.12360, PubMed 26791677

Publications 2015

Jørgenrud B, Jalanko M, Heliö T, Jääskeläinen P, Laine M, Hilvo M, Nieminen MS, Laakso M, Hyötyläinen T, Orešič M, Kuusisto J (2015)
The Metabolome in Finnish Carriers of the MYBPC3-Q1061X Mutation for Hypertrophic Cardiomyopathy
PLoS One, 10 (8), e0134184
DOI 10.1371/journal.pone.0134184, PubMed 26267065

Jørgenrud B, Jäntti S, Mattila I, Pöhö P, Rønningen KS, Yki-Järvinen H, Orešič M, Hyötyläinen T (2015)
The influence of sample collection methodology and sample preprocessing on the blood metabolic profile
Bioanalysis, 7 (8), 991-1006
DOI 10.4155/bio.15.16, PubMed 25966010

Publications 2013

Berg T, Jørgenrud B, Strand DH (2013)
Determination of buprenorphine, fentanyl and LSD in whole blood by UPLC-MS-MS
J Anal Toxicol, 37 (3), 159-65
DOI 10.1093/jat/bkt005, PubMed 23423312